Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 171.09
-2.13 (-1.23%)
At close: Sep 11, 2026
NSE:GKSL Revenue
Gujarat Kidney And Super Speciality had revenue of 342.89M INR in the quarter ending June 30, 2026, with 124.70% growth. This brings the company's revenue in the last twelve months to 1.01B, up 118.86% year-over-year. In the fiscal year ending March 31, 2026, Gujarat Kidney And Super Speciality had annual revenue of 820.13M with 103.80% growth.
Revenue (ttm)
1.01B
Revenue Growth
+118.86%
P/S Ratio
13.35
Revenue / Employee
5.21M
Employees
n/a
Market Cap
13.49B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 820.13M | 417.71M | 103.80% |
| Mar 31, 2025 | 402.42M | 354.68M | 742.89% |
| Mar 31, 2024 | 47.74M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 7.86M | -3.17M | -28.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jupiter Life Line Hospitals | 15.58B |
| Indraprastha Medical Corporation | 15.24B |
| Shalby | 11.76B |
| Artemis Medicare Services | 11.14B |
| Nephrocare Health Services | 10.54B |
| Jeena Sikho Lifecare | 8.51B |
| GPT Healthcare | 4.92B |
| Max India | 2.39B |